﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Renal Injury Prevention</JournalTitle>
      <Issn>2345-2781</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>07</Month>
        <DAY>17</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Correlation between MEST-C score in kidney biopsy of IgA nephropathy patients with prognosis</ArticleTitle>
    <FirstPage>e32275</FirstPage>
    <LastPage>e32275</LastPage>
    <ELocationID EIdType="doi">10.34172/jrip.2024.32275</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ellahe</FirstName>
        <LastName>Sanei</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6665-8516</Identifier>
      </Author>
      <Author>
        <FirstName>Abolfazl</FirstName>
        <LastName>Akhond</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-5592-8285</Identifier>
      </Author>
      <Author>
        <FirstName>Sina</FirstName>
        <LastName>Ashouri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0004-6554-7733</Identifier>
      </Author>
      <Author>
        <FirstName>Soudeh</FirstName>
        <LastName>Arastouei</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1087-9982</Identifier>
      </Author>
      <Author>
        <FirstName>Indira</FirstName>
        <LastName>Giri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0003-6979-3838</Identifier>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Mehrdad-Majd</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8745-6558</Identifier>
      </Author>
      <Author>
        <FirstName>Malihe</FirstName>
        <LastName>Saberafsharian</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0115-8016</Identifier>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Miri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9962-6753</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jrip.2024.32275</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>12</Month>
        <Day>05</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>03</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis, and is the most common type of glomerulopathy which leading to end-stage renal disease (ESRD). Prompt diagnosis of high-risk patients is important to initiate specific treatment early and prevent progression to ESRD. Oxford pathological classification, known as MEST-C score, attempts to predict prognosis based on pathological factors. Objectives: In this study, we evaluated the value of pathological and clinical variables in estimating the prognosis of IgAN in Iranian patients. Patients and Methods: In this retrospective cohort study, 165 specimens were reviewed by a nephropathologist, who reported the MEST-C score after the definitive diagnosis of IgAN. Patient records were reviewed to gather clinical data, including serum creatinine, 24-hour urine protein levels, diagnosis of hypertension and/or diabetes, and any treatment received. The pre-specified endpoints were determined as progression to ESRD, a reduction in estimated glomerular filtration rate (eGFR) to less than 50% of its baseline, performance of renal transplant, or death. The variables were compared in patients who had reached the pre-specified endpoints and those who had not, to estimate their prognostic value. Results: Findings showed that the urinary protein level and T-score on biopsy were significant prognostic factors. Other pathological factors such as C, S, and M scores lost their significance on multivariate analysis. Further research is needed to validate the efficacy of the MEST- C score in different racial populations. Conclusion: In our study, urinary protein level at diagnosis and T-score on biopsy were validated as prognostic factors, while M, E, S and C scores were not deemed significant. Further research is necessary to validate the MEST-C scoring system in different populations before its use in routine clinical practice.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">MEST</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">IgA nephropathy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Prognosis</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>